COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

The Pharma Fast 50

PharmaTimes presents Alantra’s annual ranking of the fastest growing private pharma companies in the UK
Powerful progress

Veeva’s predictions for the life sciences industry in 2021
Cash controllers

Oli Hudson and Steve How, of Wilmington Healthcare, explore how NHS England’s new system-level funding works and the impact on prescribing for high cost drugs

News

View all

GW Pharma’s Epidyolex scores new EU indication

Cannabis-based medicine approved for the treatment of seizures associated with tuberous sclerosis complex

21st April 2021

J&J resumes roll-out of COVID-19 vaccine in EU

EMA's safety committee has confirmed the overall benefit-risk profile of the jab

21st April 2021

Novartis’ MS therapy Kesimpta wins NICE backing

First self-administered, targeted B-cell therapy licensed for adults with relapsing forms of MS

21st April 2021

UK government launches search for at-home COVID-19 treatments

Antivirals Taskforce established in a bid to identify promising at-home antiviral medicines

21st April 2021

Real-world data suggests Sputnik V vaccine is 97.6% effective, says RDIF

Data comes from 3.8 million Russians vaccinated with COVID-19 vaccine

20th April 2021

Web Exclusives

View all

NICE steps into the future

Sharmila Nebhrajani on the Institute's new five-year strategy to help bring the benefits of innovations to patients more quickly

Humanising pharma for a new world through design

Through strong brand communication and design, we are starting to see a new side to pharma and life science and healthcare sectors

Opportunities for innovation

Why innovation and continued virtual engagement is key to the future success of the med tech industry

Lock and key

The key three cybersecurity concerns for the pharmaceutical industry in 2021

Magazine

View more from the latest edition

Divided opinion

Amgen v Sanofi: narrowing the scope of protection for antibody inventions?

MAGAZINE EXCLUSIVE

Supply chain security

Is blockchain the answer to protecting against counterfeits and medicines shortages?

MAGAZINE EXCLUSIVE

SMART PEOPLE: Jenny Ousbey

OVID Health founder Jenny Ousbey discusses the pandemic, patient advocacy and the Patient Partnership Index

Patient Files: HIV

Samantha Dawson details her experiences living with HIV

Thumbnail image for HIV: the fight continues

Gilead Sciences’ global patient engagement lead and former HIV nurse specialist Geraldine Reilly explores today’s fight against the virus – as TV series It’s A Sin brings back memories of working on the frontline during the AIDS epidemic of the 1980s and 1990s

Smart People: Dr Nick West

Abbott’s Dr Nick West talks to PharmaTimes about going beyond intervention to improve the care of cardiovascular patients in the UK

The first fallout

Taking a look at the recent dispute between the EU Commission and AstraZeneca over the ins and outs of its contract, Stuart Evans, commercial litigation expert and partner at law firm BLM, examines what this could represent for EU/UK cross-border pharma relations

Thought Leadership

View all

Training the next generation of healthcare leaders

The global COVID pandemic has highlighted the need for expert leadership in global healthcare. Oxford University is rising to the challenge, pulling together specialists from business and medical departments to launch an MSc in Global Healthcare Leadership